Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000905148-21-000697
Filing Date
2021-11-04
Accepted
2021-11-04 16:15:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 efc21-587_sc13d.htm SC 13D 218873
  Complete submission text file 0000905148-21-000697.txt   220386
Mailing Address 1700 OWENS STREET SUITE 595 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET SUITE 595 SAN FRANCISCO CA 94158 415-522-0100
venBio Global Strategic Fund III, L.P. (Filed by) CIK: 0001739920 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 662 ENCINITAS BLVD., STE. 250 ENCINITAS CA 92024
Business Address 662 ENCINITAS BLVD., STE. 250 ENCINITAS CA 92024 (858) 945-2393
Ventyx Biosciences, Inc. (Subject) CIK: 0001851194 (see all company filings)

EIN.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92974 | Film No.: 211380169
SIC: 2834 Pharmaceutical Preparations